Farxiga/Forxiga (dapagliflozin) Disease area(s): Metabolic diseases Manufacturer(s): AstraZeneca 2024 Sales (USD): $7.72 billion Why it sold so well: In 2024, AstraZenecas Farxiga achieved robust sales growth, with revenues increasing by 21% year-over-year to $1.9 billion in the fourth quarter alone and by 28% compared to 2023, making it the companys top seller in 2024
These trends were also observed in the resistome, especially with regards to specific ABR genes of the classes of aminoglycosides, beta-lactams and tetracycline (Figs 7 and 8), thus indicating and confirming that this antimicrobial treatment can induce specific, reproducible and predictable changes 6
doi: 10.3390/cells11132058
02 Vitals are checked, hydration and nutrition needs are assessed, and the infusion setup is prepared under sterile clinical protocols 03 A controlled dose of Glutathione is administered intravenously, allowing direct absorption into the bloodstream 04 Vitamin C, skin boosters, or antioxidant blends may be added to enhance whitening, detox, and immunity benefits